Prostate cancer study looks at hormone therapy, androgen suppression
September 23, 2013 (CHICAGO) (WLS) -- Prostate cancer patients may do just fine with fewer weeks of hormone therapy before they begin radiation treatment. Also, a new study finds cutting back on androgen suppression treatment also reduces difficult side effects.
Researchers studied more than 14,000 intermediate risk prostate cancer patients for an average of nine years. The men were divided into two groups.
One group received eight weeks of hormone therapy before beginning radiation and the second group received 28 weeks of the treatment.
Researchers at the Mayo Clinic say overall both groups had a similar survival rate after they received eight weeks of radiation. But those patients who received the longer course of hormone therapy had more side effects including hot flashes and erectile dysfunction.
The study is being presented today at the American Society for Radiation Oncology (ASTRO) 55th Annual Meeting which is being held in Atlanta.
- Lake Shore Drive closed Wilson to Foster 1 min ago
- Man, 20, charged in Boystown sex assault
- Neighbors rescue kids from West Pullman fire
- ABC7 First Alert Weather Forecast
- Chicago casino plans to be heard at Wednesday hearing
- Carl Sandburg H.S. on 'soft lockdown'
- Bucktown water main break gushes for hours
- Cubs unveil plans for Wrigley's 100th birthday
- Michelle Obama to meet with CPS students in DC
- Amber Creek murder suspect appears at preliminary hearing
- Resurfacing project begins to fill potholes
- Gurnee man sentenced in sex assaults of 2 kids
- Huntley teen charged, allegedly crashed SUV into home
- Truck driver who allegedly molested 11 kids sentenced
Most Viewed StoriesMost Viewed Photos